She should win her place thanks to good results, says Radwanska
NADA's Anti Doping Appeals Panel (ADAP), headed by Justice R V Easwar, set aside the Anti Doping Disciplinary Panel's (ADDP) verdict of four-year suspension after the athlete approached the appeals panel.
'Sharapova has been a US resident since early in her career, which does bring in a question of how or why she is using a drug that is not licensed there'
A summary of sports events and persons who made news on Thursday.
One of Maria Sharapova's biggest sponsors, Nike Inc., said it was suspending ties while the case is being investigated.
A lengthy ban for doping would be devastating for five-times grand slam champion Maria Sharapova but she would survive it, Nick Bollettieri, the man who discovered her, said on Tuesday.
The court said no hearing date had been fixed yet and no further information would be provided for the moment.
Former world number one Maria Sharapova made a winning comeback to the tour on Wednesday following her 15-month doping ban, beating Italian Roberta Vinci in straight sets in the first round of the Stuttgart Grand Prix.
Five-times Grand Slam champion Sharapova became an ambassador for the UN Development Programme (UNDP) in 2007, but was dropped in March after admitting she had used the banned substance meldonium.
Russian tennis chief Shamil Tarpishchev expects Maria Sharapova to represent her country at this year's Olympics in Brazil despite being provisionally suspended from the game after testing positive for a banned substance.
Sharapova, 29, had called the ITF's original ruling "unfairly harsh" because she had not intentionally violated anti-doping rules.
Winter Games' least taxing and physically demanding sports feel it necessary to use performance-enhancing drugs
Maria Sharapova's lawyer blasted WADA chief Craig Reedie for making remarks about the five-times grand slam champion at a conference in London on Monday and said the Russian tennis player was owed an apology.
Factbox on Russia's Maria Sharapova who was banned until January 2018 on Wednesday after testing positive for the banned drug meldonium at this year's Australian Open.
Take a look at the profile of Maria Sharapova who told a news conference on Monday she failed a drugs test.
Maria Sharapova will miss next month's Rio Olympics after the Court of Arbitration for Sport (CAS) on Monday decided to defer its decision on the Russian multiple grand slam champion's appeal against a two-year doping ban until September. Sharapova was seeking to have her ban, which was imposed on her by the International Tennis Federation (ITF) in June, wiped out or reduced and a decision was initially expected to be announced by July 18.
World indoor 1500 metres champion Abeba Aregawi has been suspended from Swedish athletics after she tested positive for a banned substance, the national federation said on Monday.
Maria Sharapova will probably have to win 10 matches to claim a second Wimbledon title this year after deciding on Friday not to request a wildcard for the championships.
The 30-year-old Russian, who has won five Grand Slams and is among the highest-paid athletes in the world, returned to action on Wednesday with a straight sets win over Roberta Vinci following her suspension for the use of banned substance meldonium.
Former world number one Maria Sharapova will make her first Grand Slam appearance in over 18 months after she was awarded a main-draw wildcard for the upcoming US Open, the tennis tournament's organisers confirmed on Tuesday.
Five-time Grand Slam champion Maria Sharapova is putting her time away from tennis to good use.
Former champion Maria Sharapova's hopes of playing at this year's Wimbledon championships could hinge on a June 20 meeting of tournament organisers unless the Russian hits form in forthcoming events in Madrid and Rome.
Jagtar's urine sample 'A', collected during the Federation Cup National Championships in Patiala last month by the NADA, has returned positive for meldonium and he has been put under provisional suspension.
A stone-faced Sharapova was left to ponder a 6-1, 6-1 drubbing that proved once again Williams has all the answers when the pair meet on court.
Former World No 1 Maria Sharapova is expected to face a disciplinary hearing over a drug violation in June.
The 30-year-old Russian, who made her comeback last month after serving a suspension following a positive test for heart drug meldonium at last year's Australian Open, had hoped for a favour from the French Tennis Federation (FFT) because her ranking, currently 211, does not warrant an automatic place.
The Kremlin's spokesman said on Wednesday that a failed drug test by Russian tennis star Maria Sharapova should not be "projected onto" the whole of Russian sport.
World number one Andy Murray is against giving wild cards to players returning from doping bans but the 29-year-old understands why tournament organisers make an exception for "big names".
The news comes after Sharapova, who said the decision to end their four-year partnership was "mutually agreed", was beaten by 44th-ranked Naomi Osaka in the first round of the BNP Paribas Open in California on Wednesday.
Serena Williams may have been second best at the French Open on Saturday but the American has moved ahead of fellow tennis player Maria Sharapova to top the women's earnings list in sports, according to Forbes Magazine. Williams ended the Russian's 11-year reign as the world number one women's money earner in sports by hauling in $28.9 million in combined prize money and off-field earnings over the past 12 months, the magazine said on Monday. Sharapova, who lost some sponsorship money after announcing she had tested positive for the recently banned substance meldonium at the Australian Open in January and is provisionally suspended, holds second spot at $21.9 million.
Russian Yulia Efimova, who won two Olympic silver medals this month after being cleared to compete in Rio following a doping ban, has compared swimming in the Games to being at war. Initially excluded from the event because of her doping record, the 24-year-old won a last-minute legal challenge to the Court of Arbitration for Sport (CAS) and finished second in the 100 and 200 metres breaststroke in Brazil. "I felt under pressure from the sportsmen, the fans, the press. This was awful and it was not like being at an Olympics, which usually unites people. This was not a competition, but a war - a old war," Efimova told a news conference on Wednesday.
Maria Sharapova withdrew from the Rogers Cup with a sore left arm on Thursday, putting the five-time grand slam champion's US Open participation in doubt.
The glittering career of Russian former World No 1 Maria Sharapova was in tatters after she was given a two-year ban by the International Tennis Federation. Check out the high points in her career...
Angelique Kerber's build-up for next week's Australian Open suffered a setback with the German world number one going down in straight sets to Russian teenager Daria Kasatkina in the second round of the Sydney International.
Maria Sharapova has been suspended as a goodwill ambassador by the United Nations after the former world number one admitted she had tested positive for the banned substance meldonium at this year's Australian Open.
Spanish tennis maestro Rafael Nadal has defended his training methods and outrightly rejected to have used any banned substance in order to speed up his recovery from injury.
'No words, games, or actions will ever stop me from reaching my own dreams. And I have many'
Maria Sharapova can rise above the furore surrounding her return from a 15-month doping ban if she accepts the decision to deny her a wild card entry to the French Open without rancour, former world number three Pam Shriver has said.
'I definitely feel the respect from the athletes. Certainly when I play against them, in terms of the level they play with'
Maria Sharapova shook off some rust after injury and a 15-month doping ban to beat Jennifer Brady in her first match in the United States in more than two years on Monday at the Stanford Classic.
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances